As shown in Table 5, among the treatment-related AEs in the mutant driver genes group, neutropenia had the highest incidence (22.67%), followed by anemia (20.00%), leukopenia (17.33%), elevated ALT or AST (13.33%), and febrile neutropenia (10.67%). This evidence concerns the gene GPT and Decreased total neutrophil count.